Citric Acid → Aspirin potassium

HRID 2040495ノート

反応式

HRID 2040495 の反応式
[CH3:1][C:2]([O:4][C:5]1[CH:6]=[CH:7][CH:8]=[CH:9][C:10]=1[C:11]([OH:13])=[O:12])=[O:3].C(=O)(O)[O-].C(O)(=O)CC(CC(O)=O)(C(O)=O)O.C(=O)(O)[O-].[K+:35]>O>[C:2]([O:4][C:5]1[C:10](=[CH:9][CH:8]=[CH:7][CH:6]=1)[C:11]([O-:13])=[O:12])(=[O:3])[CH3:1].[K+:35]

参加物

6

反応物 4

HCID 311Citric AcidHCID 769Bicarbonate Ion5 回HCID 2244Aspirin6 回HCID 516893Potassium Bicarbonate

生成物 1

HCID 23676700Aspirin potassium

試薬・触媒・溶媒 1

HCID 962Water溶媒

実験手順

The soluble aspirin composition of the present disclosure is formulated so that all aspirin is bound to particles of bicarbonate, i.e., the composition contains no non-agglomerated aspirin. The granules, containing aspirin, powdered heat-treated bicarbonate salt, resin and surfactant, are in mixture with crystalline particles of pharmaceutically-acceptable acid, such as citric acid, and crystalline particles of heat-treated bicarbonate salt, e.g., potassium bicarbonate. When the soluble aspirin composition is introduced to water or other aqueous medium, the pharmaceutically acceptable acid crystals and the heat-treated bicarbonate salt crystals strongly react with one another to effect effervescence and mixing of the composition in the liquid volume, and the pharmaceutically acceptable acid crystals react with the heat-treated bicarbonate salt in the granules to reactively break up and disperse the granules, with the reaction involving the aspirin in the granules, to yield potassium acetylsalicylate, which immediately dissolves in the aqueous medium without residue.

後処理

  1. additionmixing of the composition in the liquid volume
  2. additiondisperse the granules

出典と根拠

ORDレコード
ord-ea1fe9dfe4e047fc9024ac3390ce7fe0
出典データセット
uspto-grants-2013_11
特許番号
US08580853B2

反応ノート

読み込み中…